Literature DB >> 7531431

Endoscopic stenting for malignant biliary obstruction.

K L Cheung1, E C Lai.   

Abstract

OBJECTIVE: To evaluate the results of endoscopic stenting in patients with malignant biliary obstruction.
DESIGN: Retrospective review.
SETTING: Surgical endoscopy unit at a tertiary referral center. PATIENTS AND INTERVENTION: Plastic endoprosthetic stents were inserted for the relief of biliary obstruction in 131 consecutive patients. Among the 104 patients with malignant biliary obstruction, 60 underwent stenting as definitive palliative treatment. MAIN OUTCOME MEASURES: Data on the type and size of stents employed, their effectiveness in relieving jaundice, their complications, and the quality of survival were analyzed.
RESULTS: Median survival was 1.93 months. The majority of the stents (88.3%) were placed endoscopically, and single straight stents were most frequently used (96.7%). Jaundice was relieved in 35 patients. Early (< or = 14 days) and late acute cholangitis were found in four and 11 patients, respectively. Early and late stent migration was noticed in two and six patients, respectively. Pancreatitis occurred in one patient, and no papillotomy site bleeding was encountered. When compared with the 18 patients with proximal obstruction at or above the common hepatic duct, the 42 patients with distal ductal obstruction had longer median survival (P = .03) and more effective relief of jaundice (P = .005) and required less antibiotic treatment (P = .03). These 42 patients also enjoyed better quality of survival when it was analyzed with reference to six objective parameters (P = .0018).
CONCLUSIONS: Stenting offers palliation of malignant biliary obstruction, and the results are particularly encouraging in distal obstruction.

Entities:  

Mesh:

Year:  1995        PMID: 7531431     DOI: 10.1001/archsurg.1995.01430020094018

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

Review 1.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 2.  Biliary and gastric bypass or stenting in nonresectable periampullary cancer: analysis on the basis of controlled trials.

Authors:  A Schwarz; H G Beger
Journal:  Int J Pancreatol       Date:  2000-02

3.  Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction.

Authors:  Esther H B M Tilleman; Steve M M de Castro; Olivier R C Busch; Willem A Bemelman; Thomas M van Gulik; Huug Obertop; Dirk J Gouma
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

4.  [Is there a nonsurgical therapeutic approach to cholangiocellular carcinomas?].

Authors:  M Fuchs; W Schepp
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

5.  Cholangiocarcinoma of the Hepatic Hilum (Klatskin Tumor).

Authors:  Valerie Byrnes; Nezam Afdhal
Journal:  Curr Treat Options Gastroenterol       Date:  2002-04

6.  Multicenter Randomized Trial of 10-French versus 11.5-French Plastic Stents for Malignant Biliary Obstruction.

Authors:  Mihir S Wagh; Mario de Bellis; Evan L Fogel; James T Frakes; John F Johanson; Tahir Qaseem; Douglas A Howell; Glen A Lehman; Stuart Sherman
Journal:  Diagn Ther Endosc       Date:  2013-05-02

Review 7.  Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review.

Authors:  Geng Zhimin; Hidayatullah Noor; Zheng Jian-Bo; Wang Lin; Rajiv Kumar Jha
Journal:  Med Sci Monit       Date:  2013-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.